IP Library Granted Patent US 8,273,860
Granted Patent B2
US 8,273,860 · App. 13/287,494 · Granted Sep 25, 2012

Imatinib immunoassay

Assignee: Saladax Biomedical Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,273,860
App. No.
13/287,494
Granted
Sep 25, 2012
Kind
B2
Abstract

Novel conjugates and immunogens derived from imatinib and monoclonal antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of imatinib or its pharmacologically active salts in biological fluids.

Claims (36)

1. A compound of the formula:

or its pharmacologically active salts;

wherein Y is an organic spacing group;

X is a terminal functional group capable of binding to a carrier containing an amino or thiol group through said amino or thiol group and;

p is an integer from 0 to 1.

2. The compound of claim 1 , wherein Y is alkylene containing from 1 to 10 carbon atoms,

wherein n and o are integers from 0 to 6, and m is an integer from 1 to 6.

3. The compound of claim 2 , wherein p is 1.

4. The compound of claim 3 , wherein X is

wherein R 3 is hydrogen or taken together with its attached oxygen atom forms a reactive ester and R 4 is oxygen or sulfur.

5. The compound of claim 4 , wherein X is

and R 3 forms a reactive ester.

6. A composition comprising a carrier containing a polymer having either a reactive thiol or amino group conjugated with a compound of the formula:

or its pharmacologically active salts;

wherein Y is an organic spacing group;

X is a terminal functional group involved in the binding to said carrier through said amino or thiol group and;

p is an integer from 0 to 1.

7. The compound of claim 6 , wherein Y is alkylene containing from 1 to 10 carbon atoms,

wherein n and o are integers from 0 to 6, and m is an integer from 1 to 6.

8. The conjugate of claim 7 , wherein p is 1.

9. The conjugate of claim 8 , wherein X is

wherein R 3 is hydrogen or taken together with its attached oxygen atom forms a reactive ester and R 4 is oxygen or sulfur.

10. An immunogen comprising an immunogenic carrier containing a polymer having either a reactive thiol or amino group conjugated with a compound of the formula:

or its pharmacologically active salts;

wherein Y is an organic spacing group;

X is a terminal functional group involved in the binding to said carrier through said amino or thiol group and;

p is an integer from 0 to 1.

11. The compound of claim 10 , wherein Y is alkylene containing from 1 to 10 carbon atoms,

wherein n and o are integers from 0 to 6, and m is an integer from 1 to 6.

12. The compound of claim 11 , wherein p is 1.

13. The compound of claim 12 , wherein X is

wherein R 3 is hydrogen or taken together with its attached oxygen atom forms a reactive ester and R 4 is oxygen or sulfur.

14. The compound of claim 12 , wherein X is

and R 3 forms a reactive ester.

15. The compound of claim 14 , wherein the immunogenic carrier containing the polymer contains one or more amino groups linked by

wherein R 4 is oxygen or sulfur.

Assignments (1)
SECURITY INTEREST Recorded Nov 17, 2015
From: SALADAX BIOMEDICAL, INC.
To: SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Reel/Frame 037126/0733 →
Continuity (2)
Division 12543699 · Aug 19, 2009
Related Publication 20120045470A1 · Feb 23, 2012